Phocas Financial Corp.
- SEC CIK
- 0001356783
- Latest filing
- Jul 30, 2026
SUPN holding history
Supernus Pharmaceuticals, Inc. in every 13F filed by Phocas Financial Corp., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings
- Shares (Q2 2026)
- 60,253
- Value
- $2.80M
- % of portfolio
- 0.4%
- Quarters held
- 15
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 60,253 | $2.80M | 0.4% | −3,160−5.0% | Reduced | Holders |
| Q1 2026 | 63,413 | $3.28M | 0.5% | −17,907−22.0% | Reduced | Holders |
| Q4 2025 | 81,320 | $4.04M | 0.5% | +81,320 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −102,550−100.0% | Sold out | Holders |
| Q1 2025 | 102,550 | $3.36M | 0.5% | −5,929−5.5% | Reduced | Holders |
| Q4 2024 | 108,479 | $3.92M | 0.5% | −981−0.9% | Reduced | Holders |
| Q3 2024 | 109,460 | $3.41M | 0.5% | −6,883−5.9% | Reduced | Holders |
| Q2 2024 | 116,343 | $3.11M | 0.5% | −2,199−1.9% | Reduced | Holders |
| Q1 2024 | 118,542 | $4.04M | 0.6% | −3,017−2.5% | Reduced | Holders |
| Q4 2023 | 121,559 | $3.52M | 0.5% | −35,507−22.6% | Reduced | Holders |
| Q3 2023 | 157,066 | $4.33M | 0.6% | −150−0.1% | Reduced | Holders |
| Q2 2023 | 157,216 | $4.73M | 0.6% | −878−0.6% | Reduced | Holders |
| Q1 2023 | 158,094 | $5.73M | 0.8% | −16,852−9.6% | Reduced | Holders |
| Q4 2022 | 174,946 | $6.24M | 0.9% | +42,348+31.9% | Added | Holders |
| Q3 2022 | 132,598 | $4.49M | 0.7% | +26,493+25.0% | Added | Holders |
| Q2 2022 | 106,105 | $3.07M | 0.5% | +106,105 | New | Holders |